Cargando…
Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
BACKGROUND: Most birch pollen‐allergic patients develop allergic cross‐reactions to the major allergen found in apples Mal d1, known as pollen‐related food allergy (prFA). This is due to a strong clinically relevant homology between the major allergen in birch Bet v 1 and Mal d 1. Daily apple consum...
Autores principales: | Nothegger, B., Reider, N., Covaciu, C.E., Cova, V., Ahammer, L., Eidelpes, R., Unterhauser, J., Platzgummer, S., Tollinger, M., Letschka, T., Eisendle, K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318684/ https://www.ncbi.nlm.nih.gov/pubmed/31953891 http://dx.doi.org/10.1111/jdv.16201 |
Ejemplares similares
-
Oral birch pollen immunotherapy with apples: Results of a phase II clinical pilot study
por: Nothegger, Bettina, et al.
Publicado: (2021) -
Ascorbylation of a Reactive Cysteine in the Major Apple Allergen Mal d 1
por: Ahammer, Linda, et al.
Publicado: (2022) -
Defining and measuring ‘eczema control’: an international qualitative study to explore the views of those living with and treating atopic eczema
por: Howells, L., et al.
Publicado: (2019) -
Both children and adult patients with difficult‐to‐treat atopic dermatitis have high prevalences of concomitant allergic contact dermatitis and are frequently polysensitized
por: Boonstra, M., et al.
Publicado: (2018) -
The patient‐reported disease burden in adults with atopic dermatitis: a cross‐sectional study in Europe and Canada
por: de Bruin‐Weller, M., et al.
Publicado: (2020)